Activation-synthesis hypothesis

From WikiMD's WELLNESSPEDIA

Activation-synthesis hypothesis is a neurobiological theory proposed by J. Allan Hobson and Robert McCarley in 1977, which suggests that dreams are a result of the brain's attempt to interpret random neural activity during REM sleep.

Overview[edit]

The activation-synthesis hypothesis proposes that the initial randomness of REM sleep is generated in the brainstem, particularly in the pons, where many of the signals originate. These signals are then sent to the cerebral cortex, which attempts to synthesize and interpret them, resulting in the experience of dreaming.

Process[edit]

The process begins with the activation of the neurotransmitter systems in the brainstem, including the acetylcholine system. This activation leads to the random firing of neurons, which the cerebral cortex then attempts to interpret and make sense of. The result is a dream, which can often seem bizarre or nonsensical due to the random nature of the neural activity.

Criticisms[edit]

While the activation-synthesis hypothesis has been influential in the field of dream research, it has also been subject to criticism. Some researchers argue that it does not account for the often meaningful and coherent nature of dreams. Others suggest that it does not explain why we remember some dreams but not others.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.